N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺

N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺性质、用途与生产工艺

用途

N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺是一种利用LC-MS技术对柠檬酸托法替尼降解产物进行过程监控和质量保证的相关物质鉴别的物质。是合成托法替尼的试剂，托法替尼是一种Janus酪氨酸激酶(JAK3)特异性抑制剂。

N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 上下游产品信息

上游原料

下游产品

N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 生产厂家

477600-74-1, N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 相关搜索:

• 高端化学
• 医用原料
• 076-托法替尼
• 医药原料
• 杂质对照品
• 标准品
• 托法替尼杂质
• 医药中间体
• 托法替尼中间体
• 托法替布中间体
• 477660-74-1
• 托法替布C006非对应异构体(盐酸盐)
• 托法替布杂质18(N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺)
• 托法替尼中间体32
• 托法替尼杂质343
• 台历托法替尼
• HC1309-202
• 托法替布杂质M
• 托法替尼 N-去氰乙酰杂质
• (3R,4R)-甲基-(4-甲基-哌啶-3-基)-(7H-吡咯并[2,3-D]嘧啶-4-基)胺
• N-甲基-N-((3R,4R)-4-甲基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺N-METHYL-N-[(3R,4R)-4-METHYLPIPERIDIN-3-YL]-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
• 托法替尼杂质32
• 托法替尼杂质(M9-RR)
• 托伐替尼杂质M
• 托伐替尼杂质F
• 托法替尼杂质41
• N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺
• 托法替尼杂质M(3S,4R)
• N-甲基-N-((3R,4R)-4-甲基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺
• 托法替尼杂质 L
• 477600-74-1
• Tofatinib Impurity F
• Tofatinib Impurity 41
• N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
• tofacitinib intermediate
• Tofacitinib N-1
• 1H-Pyrrolo[2,3-d]pyrimidin-4-amine,N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-
• N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 477600-74-1
• N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine bis(2,2,2-trifluoroacetate)
• Azilsartan medoxomil impurity343
• N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-1H-Pyrrolo[2,3-d]pyrimidin-4-amine
• Tofacitinib Impurity-M(debenzylated)
• N-METHYL-N-((3R,4R)-4-METHYLPIPERIDIN-3-YL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE (CAS NO.477600-74-1)
• N-Methyl-N-[(3R,4R)-4-methyl-3-piperidyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
• Tofacitinib N-Descyanoacetyl Impurity
• N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amin
• Tofacitinib impurity 7/N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
• Tofacitinib N-Descyanoacetyl
• Tofacitinib-11
• TF-G
• N-methyl-N-((3S,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
• N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-1H-pyrrolo[2,3-d]pyrimidin-4-amine
• Tofacitinib IMpurity M
• N-Methyl-N-[(3R,4R)-4-Methylpiperidin-3-yl]-7H-pyrrolo[2,3-d]
• H-Pyrrolo[2,3-d]pyriMidin-4-aMine
• 1H-Pyrrolo[2,3-d]pyriMidin-4-aMine,N-Methyl-N-[(3R,4R)-4-Methyl-3-piperidinyl]- (9CI)
• (3R,4R)-Methyl{(4-Methylpiperidin-3-yl)(7H-pyrrolo[2,3-d]pyriMidin-4-yl)}aMine
• N-Methyl-N-((3R,4R)-4-Methyl-piperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine